National Institutes of Health: Herpes Zoster trials

The registry lists 14 Herpes Zoster studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 5Phase 2 7Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control PopulationRecruitingNCT05580458Phase 1/2
• Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)CompletedNCT03702231Phase 2Results posted
• Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral TherapyCompletedNCT00851786Phase 2Results posted
• ZOSTAVAX® in Renal Transplant PatientsCompletedNCT01137669Phase 1
• Immune Response to Varicella-Zoster Vaccination and InfectionCompletedNCT00921999
• Immune Responses to Two Dose Varivax +/- MMR-IITerminatedNCT00258726Phase 1/2
• Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255
• Shingles: Immune Effects of Tai ChiCompletedNCT00118885Phase 2
• Tai Chi Chih and Varicella Zoster ImmunityCompletedNCT00029484Phase 2
• Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes ZosterCompletedNCT00006131Not applicable
• Evaluation of the Safety of Varivax® in Pediatric Renal Transplant RecipientsTerminatedNCT00005009Phase 1
• Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic NeuralgiaCompletedNCT00004390Phase 3
• Dextromethorphan Versus Placebo for Neuropathic PainCompletedNCT00001344Phase 2
• Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had ChickenpoxCompletedNCT00001125Phase 1